RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Dicerna Pharmaceuticals Stock

Dicerna Pharmaceuticals P/E 2024

Dicerna Pharmaceuticals P/E

-19

Ticker

DRNA

ISIN

US2530311081

WKN

A1XCYU

As of Nov 27, 2024, Dicerna Pharmaceuticals's P/E ratio was -19, a 0% change from the 0 P/E ratio recorded in the previous year.

The Dicerna Pharmaceuticals P/E history

Dicerna Pharmaceuticals Aktienanalyse

What does Dicerna Pharmaceuticals do?

Dicerna Pharmaceuticals Inc. is a biopharmaceutical company based in the United States that focuses on RNA interference (RNAi). It was founded in 2007 and is headquartered in Lexington, Massachusetts. It also has branches in Germany and Switzerland. Dicerna Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Dicerna Pharmaceuticals's P/E Ratio

The Price to Earnings (P/E) Ratio of Dicerna Pharmaceuticals is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Dicerna Pharmaceuticals's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Dicerna Pharmaceuticals is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Dicerna Pharmaceuticals’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Dicerna Pharmaceuticals stock

What is the price-to-earnings ratio of Dicerna Pharmaceuticals?

The price-earnings ratio of Dicerna Pharmaceuticals is currently -19.

How has the price-earnings ratio of Dicerna Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Dicerna Pharmaceuticals has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Dicerna Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Dicerna Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Dicerna Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Dicerna Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Dicerna Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Dicerna Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Dicerna Pharmaceuticals?

Some factors that influence the price-earnings ratio of Dicerna Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Dicerna Pharmaceuticals pay?

Over the past 12 months, Dicerna Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dicerna Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Dicerna Pharmaceuticals?

The current dividend yield of Dicerna Pharmaceuticals is .

When does Dicerna Pharmaceuticals pay dividends?

Dicerna Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Dicerna Pharmaceuticals?

Dicerna Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Dicerna Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Dicerna Pharmaceuticals located?

Dicerna Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dicerna Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dicerna Pharmaceuticals from 11/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/27/2024.

When did Dicerna Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/27/2024.

What was the dividend of Dicerna Pharmaceuticals in the year 2023?

In the year 2023, Dicerna Pharmaceuticals distributed 0 USD as dividends.

In which currency does Dicerna Pharmaceuticals pay out the dividend?

The dividends of Dicerna Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Dicerna Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Dicerna Pharmaceuticals

Our stock analysis for Dicerna Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dicerna Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.